My bet is big on UAMM. The direction they have taken with Cannaxa and MJCircle is genius because it serves a unique niche, low overhead, huge potential and avoids the regulations that come with direct product sales.
I mostly pointed my questions with Cannamedi out as I fully understand why it is not being rushed out. No doubt it'll be ready for 2018, but I see no upside for rushing to go active before everything is fully in place.
News 
Market Data 
Discover 
